GGrantIndex
← Leaderboards

Ying Zhang

Johns Hopkins University

$6,675,418
Attributed
$8,902,268
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$8,902,268 · 5

By mechanism

R01$6,150,248 · 3
T32$2,309,326 · 1
R21$442,694 · 1

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Mycobacterium Tuberculosis

Research focus

Mycobacterium TuberculosisPyrazinamideDrug ResistanceBasePlayPharmacokineticsTuberculosis TreatmentMutationResponseAffectPyrazinamide ResistanceMicroorganism MetabolismTuberculosis DrugsPharmaceutical PreparationsDesignPathway InteractionsGeneticInterestProtein Structure FunctionEnzyme ActivityMutantProdrugsProteinsOutcome Study

Grant awards (31)

Pyrazinamide and Trans-Translation in Mycobacterium tuberculosis$419,428
R01 · FY2015 · AI · contact PI
Toxin-antitoxins & RpsA in TB drug resistance & persistence with HIV$199,694
R21 · FY2015 · AI · contact PI
Pyrazinamide and Trans-Translation in Mycobacterium tuberculosis$424,944
R01 · FY2014 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$424,613
T32 · FY2014 · AI
Toxin-antitoxins & RpsA in TB drug resistance & persistence with HIV$243,000
R21 · FY2014 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$507,302
T32 · FY2013 · AI
Pyrazinamide and Trans-Translation in Mycobacterium tuberculosis$414,919
R01 · FY2013 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$499,422
T32 · FY2012 · AI
Pyrazinamide and Trans-Translation in Mycobacterium tuberculosis$441,456
R01 · FY2012 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$450,573
T32 · FY2011 · AI
Training: Molecular & Cellular Bases of Infectious Diseases$427,416
T32 · FY2010 · AI
Mode of Action of Pyrazinamide in Tubercle Bacillus$305,094
R01 · FY2009 · AI · contact PI
Molecular Mechanisms of TGF-beta Signaling Pathway$1,187,954
Z01 · FY2008 · CA · contact PI
Mode of Action of Pyrazinamide in Tubercle Bacillus$305,094
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of TGF-beta Signaling Pathway$1,182,286
Z01 · FY2007 · CA · contact PI
Mode of Action of Pyrazinamide in Tubercle Bacillus$310,608
R01 · FY2007 · AI · contact PI
Mode of Action of Pyrazinamide in Tubercle Bacillus$318,908
R01 · FY2006 · AI · contact PI
Molecular Mechanisms of TGF-beta Signaling Pathway$0
Z01 · FY2006 · BC · contact PI
Structure Function Analysis of TB Pyrazinamidase$367,875
R01 · FY2005 · AI
Mode of Action of Pyrazinamide in Tubercle Bacillus$324,750
R01 · FY2005 · AI
Structure Function Analysis of TB Pyrazinamidase$367,875
R01 · FY2004 · AI
Structure Function Analysis of TB Pyrazinamidase$367,875
R01 · FY2003 · AI
MODE OF ACTION OF PYRAZINAMIDE IN TUBERCLE BACILLUS$264,706
R01 · FY2003 · AI
Structure Function Analysis of TB Pyrazinamidase$367,875
R01 · FY2002 · AI
MODE OF ACTION OF PYRAZINAMIDE IN TUBERCLE BACILLUS$256,997
R01 · FY2002 · AI
Molecular mechanisms of TGF-beta signaling pathway$0
Z01 · FY2002 · BC
Structure Function Analysis of TB Pyrazinamidase$373,523
R01 · FY2001 · AI
MODE OF ACTION OF PYRAZINAMIDE IN TUBERCLE BACILLUS$262,991
R01 · FY2001 · AI
Molecular mechanisms of TGF-beta signaling pathway$0
Z01 · FY2001 · BC
MODE OF ACTION OF PYRAZINAMIDE IN TUBERCLE BACILLUS$255,330
R01 · FY2000 · AI
MOLECULAR MECHANISMS OF TGF-BETA SIGNALING PATHWAY$0
Z01 · FY2000 · BC